Mark S. Soloway

41.7k total citations · 4 hit papers
714 papers, 28.8k citations indexed

About

Mark S. Soloway is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Mark S. Soloway has authored 714 papers receiving a total of 28.8k indexed citations (citations by other indexed papers that have themselves been cited), including 312 papers in Surgery, 273 papers in Pulmonary and Respiratory Medicine and 115 papers in Urology. Recurrent topics in Mark S. Soloway's work include Bladder and Urothelial Cancer Treatments (261 papers), Prostate Cancer Treatment and Research (164 papers) and Urinary and Genital Oncology Studies (162 papers). Mark S. Soloway is often cited by papers focused on Bladder and Urothelial Cancer Treatments (261 papers), Prostate Cancer Treatment and Research (164 papers) and Urinary and Genital Oncology Studies (162 papers). Mark S. Soloway collaborates with scholars based in United States, Germany and Canada. Mark S. Soloway's co-authors include Rolf F. Barth, Francisco Civantos, Gaetano Ciancio, Murugesan Manoharan, William M. Murphy, Sandy S. Kim, Anil Vaidya, Werner Tjarks, Donald L. Lamm and Vinata B. Lokeshwar and has published in prestigious journals such as Science, New England Journal of Medicine and Chemical Reviews.

In The Last Decade

Mark S. Soloway

693 papers receiving 27.5k citations

Hit Papers

The Chemistry of Neutron ... 1988 2026 2000 2013 1998 1992 1988 2012 250 500 750 1000

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark S. Soloway 12.0k 11.2k 4.8k 4.3k 4.2k 714 28.8k
John T. Wei 4.9k 0.4× 13.3k 1.2× 1.2k 0.3× 4.7k 1.1× 5.7k 1.3× 378 23.7k
William R. Fair 7.3k 0.6× 7.2k 0.6× 1.5k 0.3× 4.1k 0.9× 2.4k 0.6× 315 17.9k
Ian M. Thompson 6.1k 0.5× 20.6k 1.8× 1.9k 0.4× 7.1k 1.6× 3.6k 0.9× 897 37.6k
Peter R. Carroll 10.2k 0.8× 30.7k 2.7× 6.5k 1.3× 7.8k 1.8× 4.1k 1.0× 880 46.0k
Yair Lotan 19.7k 1.6× 11.2k 1.0× 1.3k 0.3× 6.9k 1.6× 5.8k 1.4× 717 31.4k
Susan Groshen 11.7k 1.0× 6.2k 0.6× 1.4k 0.3× 9.1k 2.1× 2.8k 0.7× 479 31.8k
Laurence Collette 11.3k 0.9× 15.2k 1.4× 3.0k 0.6× 2.2k 0.5× 765 0.2× 317 31.6k
Hendrik Van Poppel 6.5k 0.5× 19.0k 1.7× 2.0k 0.4× 6.7k 1.5× 2.3k 0.5× 567 24.9k
Peter T. Scardino 10.1k 0.8× 40.7k 3.6× 5.2k 1.1× 8.2k 1.9× 4.2k 1.0× 738 52.0k
Eric A. Klein 6.0k 0.5× 19.7k 1.8× 2.0k 0.4× 5.0k 1.2× 2.2k 0.5× 733 29.8k

Countries citing papers authored by Mark S. Soloway

Since Specialization
Citations

This map shows the geographic impact of Mark S. Soloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Soloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Soloway more than expected).

Fields of papers citing papers by Mark S. Soloway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Soloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Soloway. The network helps show where Mark S. Soloway may publish in the future.

Co-authorship network of co-authors of Mark S. Soloway

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Soloway. A scholar is included among the top collaborators of Mark S. Soloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Soloway. Mark S. Soloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soloway, Mark S. & Neil A. Abrahams. (2024). Challenging Cases in Urothelial Cancer: Case 32. Bladder Cancer. 10(2). 163–165.
2.
Soloway, Mark S., et al.. (2014). Approaching the optimal transurethral resection of a bladder tumor. SHILAP Revista de lepidopterología. 40(2). 73–77. 7 indexed citations
3.
Dall’Era, Marc, Peter C. Albertsen, C. Bangma, et al.. (2012). Active Surveillance for Prostate Cancer: A Systematic Review of the Literature. European Urology. 62(6). 976–983. 443 indexed citations breakdown →
4.
Soloway, Mark S., et al.. (2011). MP-13.06 Complications of Open Radical Prostatectomy: More Than 18 Years Experience at One Center. Urology. 78(3). S125–S126.
5.
Soloway, Mark S., et al.. (2011). POD-07.04 Active Surveillance for Prostate Cancer: An Update on the Miami Experience. Urology. 78(3). S24–S24. 1 indexed citations
6.
Lokeshwar, Vinata B., Pablo Gómez, Mario W. Kramer, et al.. (2008). Epigenetic Regulation of HYAL-1 Hyaluronidase Expression. Journal of Biological Chemistry. 283(43). 29215–29227. 32 indexed citations
7.
Nieder, Alan M., Michael P. Porter, & Mark S. Soloway. (2008). Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study. The Journal of Urology. 180(5). 2005–2010. 133 indexed citations
8.
Golshani, Roozbeh, S. Hautmann, Verónica Estrella, et al.. (2007). HAS1 expression in bladder cancer and its relation to urinary HA test. International Journal of Cancer. 120(8). 1712–1720. 39 indexed citations
9.
Ayyathurai, Rajinikanth, Francisco Civantos, Mark S. Soloway, & Murugesan Manoharan. (2007). Basal cell carcinoma of the prostate: current concepts. British Journal of Urology. 99(6). 1345–1349. 20 indexed citations
10.
Williams, Steve K., et al.. (2007). 1410: Active Surveillance with Delayed Intervention for Localized Prostate Cancer: University of Miami Experience. The Journal of Urology. 177(4S). 465–465.
11.
Sved, Paul, Alan M. Nieder, Murugesan Manoharan, et al.. (2005). Evaluation of analgesic requirements and postoperative recovery after radical retropubic prostatectomy using long-acting spinal anesthesia. Urology. 65(3). 509–512. 14 indexed citations
12.
Gibson, Christopher R., Alfred E. Staubus, Rolf F. Barth, et al.. (2001). Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.. PubMed. 29(12). 1588–98. 10 indexed citations
13.
Sarosdy, Michael F., M’Liss A. Hudson, William J. Ellis, et al.. (1997). Improved detection of recurrent bladder cancer using the bard bta stat test. Urology. 50(3). 349–353. 165 indexed citations
15.
Liu, Lei, Rolf F. Barth, D. Adams, Mark S. Soloway, & R. Reisfeld. (1995). Bispecific Antibodies as Targeting Agents for Boron Neutron Capture Therapy of Brain Tumors. Journal of Hematotherapy. 4(5). 477–483. 34 indexed citations
16.
17.
Lim, Arthur, et al.. (1995). Bladder Neck Preservationfollowing RadicalProstatectomy:Continence and Margins. European Urology. 28(3). 202–208. 44 indexed citations
18.
Soloway, Mark S., et al.. (1992). Efficacy of Terazosin in Patients withBenign Prostatic Hyperplasia. European Urology. 21(2). 126–130. 8 indexed citations
19.
Brausi, Maurizio, et al.. (1990). Dose response relationship of methotrexate in combination with cisplatin in murine bladder cancer. Urology. 35(3). 253–256. 1 indexed citations
20.
Soloway, Mark S., et al.. (1978). Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.. PubMed. 293–300. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026